October 3-5, 2011 - Register Now! 2011 World Stem Cell Summit, The Pasadena Convention Center, Pasadena, CA.,

2011 World Stem Cell Report

World Stem Cell Report 2011 2011 World Stem Cell Report
More than 26 articles and 200 pages of previously unpublished insight into the forefront of regenerative medicine.
> View Table of Contents

Featured Speakers

Gil Van Bokkelen
business:
Gil Van Bokkelen
Read Bio >
Andrew Grove
Advocacy:
Andrew S. Grove

Read Bio >
AlanTrounson
Policy:
Alan Trounson
Read Bio >
Chris Mason
Science:
Chris Mason
Read Bio >
lawrence goldstein
Science:
Lawrence Goldstein
Read Bio >
Rudolf Jaenisch
Science:
Rudolf Jaenisch
Read Bio >

Speakers & Program Participants

Printer-friendly version

Melinda Abelman, M.Sc
Office of Embryonic Stem Cell Research Oversight
Partners Healthcare System
Boston, Massachusetts

Zami Aberman
Chairman & CEO
Pluristem Therapeutics, Inc.
Haifa, Israel

Karen S. Aboody, MD
Associate Professor, Neurosciences
Associate Professor, Neurosurgery
City of Hope
Duarte, California

Amy Adams
Communications Manager
California Institute for Regenerative Medicine
San Francisco, California

Chris Airriess, PhD
Chief Operating Officer
California Stem Cell
Irvine, California

Aileen Anderson, PhD
Associate Professor
Physical Medicine & Rehabilitation
Anatomy & Neurobiology
University of California at Irvine
Irvine, California

Gerhard Bauer, MD
Director, GMP Facility
UC Davis School of Medicine
Stem Cell Program
Sacramento, California

Steven R. Bauer, PhD
FDA/Center for Biologics Evaluation and Research
Chief, Cell and Tissue Therapy Branch 
Division of Cellular and Gene Therapies
Office of Cellular, Tissue, and Gene Therapies
Bethesda, Maryland 
 

Elona Baum, Esq.
General Counsel
California Institute for Regenerative Medicine
San Francisco, California

Cindy Bell, PhD
Executive Vice President
Corporate Development
Genome Canada
Ottawa, Canada

Ravi Bhatia, MD
Professor, Department of Hematology and HCT
Director, Division of Hematopoietic Stem Cell and Leukemia Research
Co-Director Hematological Malignancies Program, Comprehensive Cancer Center
City of Hope National Medical Center
Duarte, California

Gregory A. Bonfiglio
Proteus Venture Partners
Palo Alto, California
 

Michael Boo, JD
Chief Strategy Officer
National Marrow Donor Program
Minneapolis, Minnesota

Eugene P. Brandon, PhD
Director, Strategic Relations & Project Management
ViaCyte
San Francisco, California

Scott R. Burger, MD
Advanced Cell & Gene Therapy, LLC
Chapel Hill, North Carolina

Nissim Benvenisty, MD, PhD
Research Scientist
Cedars-Sinai Regenerative Medicine Institute
Los Angeles, California

Paula Cannon, PhD
Associate Professor
Molecular Microbiology & Immunology
USC Keck School of Medicine
Los Angeles, California

Arnold I. Caplan, PhD
Professor of Biology
Director Skeletal Research Center
Case Western Reserve University
Cleveland, Ohio

Leanna M. Caron, RPh, MBA
Vice President & General Manager
Cell Therapy & Regenerative Medicine
Genzyme Corporation
Cambridge, Massachsetts

Stephen Chang, PhD
Vice President
Research & Development
New York Stem Cell Foundation
New York, New York

Irvin S.Y. Chen, PhD
Professor of Microbiology, Immunology
and Molecular Genetics, and Medicine
Director, UCLA AIDS Institute
David Geffen School of Medicine at UCLA
Los Angeles, California

Dennis Clegg, PhD
Center Executive Director of Strategy, Planning, and Operations
Center for Stem Cell Biology and Engineering
University of California Santa Barbara
Santa Barbara, California

Arlene Chiu, PhD
Director, Office of New Research Initiatives
Beckman Research Institute
City of Hope
Duarte, California

Peter Coffey, Professor
Project Director
The London Project to Cure Blindness
UCL Institute of Ophthalmology
London, United Kingdom

Sabrina Cohen
President/Founder
Sabrina Cohen Foundation for Stem Cell Research
Miami Beach, Florida

Calvin L. Cole
President
StemCyte North America
Covina, California

C. Michael Cotten, MD, MHS
Duke University Health System
Durham, North Carolina

Larry A. Couture, PhD
Sr. Vice President
Sylvia R. and Isador A. Deutch Center
For Applied Technology Development
City of Hope
Duarte, California

Simon Craw, Phd
Vice President
International Stem Cell Corporation
Carlsbad, California

Raymond H. Cypess, DVM, PhD
Chairman, President and CEO
American Type Culture Collection (ATCC) International Bioresources Group
(IBG) Manassas, Virginia

Allen Davidoff, Ph.D.
Chief Scientific Officer,
Stem Cell Therapeutics Corp.
Calgary, Alberta

James Lawford Davies
Partner
Lawford Davies Denoon
London, United Kingdom
 

Aubrey de Grey, PhD
SENS Foundation
Mountain View, CaliforniaDave DiGiusto, PhD
Research Professor Dept. of Virology
Director - Laboratory for Cellular Medicine
Beckman Research Institute of the City of Hope

Roger De Filippo, MD, FAAP
Associate Professor
Children’s Hospital of Los Angeles, Division of Urology
Los Angeles, California

Benjamin Deverman, PhD
Division of Biology
California Institute of Technology
Pasadena, California

David DiGiusto, PhD
Research Professor Dept. of Virology
Director - Laboratory for Cellular Medicine
Beckman Research Institute of the City of Hope

Therésa K. Dixon, MBA, MS
Vice President, Government Affairs & Health Economics
Advanced BioHealing, Inc.
San Diego, California

Nathan J. Dowden
Managing Director
The Frankel Group LLC
Cambridge, Massachusetts

The Honorable James E. Doyle
Former Governor, State of Wisconsin
Of Counsel
Foley & Lardner LLP
Madison, Wisconsin

Allen Eaves, MD, PhD, FRCPC
President and CEO
Stemcell Technologies, Inc
Vancouver, British Columbia
Canada

Prof.Dr.med.Frank Emmrich
Director
Translational Centre for Regenerative Medicine
University of Leipzig
Leipzig, Germany

David Eveleth, Ph.D.
Disease Area Lead for Ophthalmology
Pfizer Inc., La Jolla Laboratories
San Diego, California

Ellen G. Feigal, M.D.
Vice President, Research and Development
California Institute for Regenerative Medicine
San Francisco, California

Leon G Fine, MD
Professor of Biomedical Sciences
Chair, Biomedical Sciences
Director, Graduate Research Education
Cedars-Sinai Medical Center
Los Angeles, California

Meri Firpo, PhD
Assistant Professor
Stem Cell Institute
Department of Medicine
University of Minnesota
Minneapolis, Minnesota

Consul General David Fransen
Consul General of Canada in Los Angeles
Los Angeles, California

Scott E. Fraser, PhD
Director
Biological Imaging Center
California Institute of Technology

Major General James K. Gilman
Commanding General
U.S. Army Medical Research and Material Command
Fort Detrick, Maryland

Lawrence S. B. Goldstein, PhD
Professor of Cellular and Molecular Medicine
University of California, San Diego
La Jolla, California

Sidney H. Golub, Ph.D.
Professor Emeritus
Dept. of Microbiology & Molecular Genetics
UCI School of Medicine
University of California, Irvine
Irvine, California

Hank Greely, JD
Deane F. and Kate Edelman Johnson Professor of Law
Professor, by courtesy, of Genetics
Director, Center for Law and the Biosciences
Stanford University
Palo Alto, California

The Honorable James C. Greenwood
President and CEO
Biotechnology Industry Organization (BIO)
Washington, DC

Tracy C. Grikscheit, MD
Attending Surgeon/Assistant Professor of Surgery
Pediatric Surgery
Keck School of Medicine
The Saban Research Institute
Childrens Hospital Los Angeles
Los Angeles, California

Karl-Henrik Grinnemo, M.D., PhD
Cardiothoracic Surgeon
Department of Cardiothoracic Surgery
Karolinska University Hospital,
Karolinska Institutet
Stockholm Sweden

Andrew S. Grove, PhD
Former CEO
Intel Corporation
San Francisco, California

Kurt C Gunter, MD, FASCP
Global Medical Director
Hematology-Oncology
Hospira Inc
Lake Forest, Illinois

Robert J. Hariri, MD, PhD
CEO
Celgene Cellular Therapeutics
Warren, New Jersey

Chris Hempel
Addi & Cassi Fund
Reno, Nevada

Roberto “Rob” Herrera
President/ Chief Business Officer
Cell Line Genetics, LLC
Madison, Wisconsin

Danny Heumann
Motivational Speaker and Founder
Heumannly Capable
Ann Arbor, Michigan

John Hlinko
Hlinko Consulting
New York, New York

Edward W. Holmes, MD,
President and Chief Executive Officer
Sanford Consortium for Regenerative Medicine
La Jolla, California

Michael C. Holmes, PhD
Senior Director, Therapeutic Gene Modification
Sangamo BioSciences, Inc.
Richmond, California

Marianne Horn, JD
Agency Legal Director
Connecticut Department of Public Health
Hartford, Connecticut

Stephen L. Huhn, MD, FAAP, FACS
VP, CNS Program
StemCells, Inc.
Palo Alto, CA

Mark S. Humayan, MD, PhD
Professor of Biomedical Engineering and Cell and Neurobiology
Associate Director, Doheny Retina Institute
University of Southern California
Los Angeles, California

Insoo Hyun, PhD
Associate Professor of Bioethics
Stem Cell Research Ethics and Public Policy
Case Western Reserve University
School of Medicine
Cleveland, Ohio

Terry R. Irgens, RPh, MS, CAAMA
Director
Armed Forces Institute of Regenerative Medicine (AFIRM)
Fort Detrick, Maryland

Rudolf Jaenisch, MD
Member, Whitehead Institute
Professor of Biology, MIT
Cambridge, Massachusetts

Alan Jakimo
Partner
Sidley Austin, LLP
New York, New York

Richard Jove, PhD
Director
Beckman Research Institute
City of Hope
Duarte, California

Armand Keating, MD, FRCP(C)
Professor of Medicine
Epstein Chair in Cell Therapy and Transplantation
Director, Division of Hematology,
Professor of Biomedical Engineering
University of Toronto
Director, Cell Therapy Program
Princess Margaret Hospital
Senior Scientist,
Division of Experimental Therapeutics,
Toronto General Research Institute,
University Health Network
Toronto, Canada

Alex Kharazi, MD, PhD
Chief Technology Officer
Stemedica Cell Technologies, Inc.
San Diego

Robert Klein, JD
Chair Emeritus of the Governing Board,
California Institute of Regenerative Medicine, San Francisco, California
Board of Chancellors, Juvenile Diabetes Research Foundation International
Chairman, Klein Financial Corporation
Palo Alto, California

Paul Knoepfler, PhD
University of California Davis
Davis, California

Nancy J. Koch
Counsel to CIRM
California Institute of Regenerative Medicine
San Francisco, California

Jason Kolbert
Neostem
New York, New York

Donald B. Kohn, MD
Depts. of M.I.M.G. and Pediatrics
University of California, Los Angeles
Los Angeles, California

Russell Korobkin
Professor of Law
UCLA School of Law
Los Angeles, California 

James J. Kovach, MD, JD
Senior Advisor for Strategic Development
CHA Health Systems
Los Angeles California
 

Dimitri Krainc, MD, PhD
Associate Professor,
Harvard Medical School
Associate Neurologist,
Massachusetts General Hospital
Boston, Massachusetts

Arnold Kriegstein, MD, PhD
Director, Ely and Edythe Broad Center of Regeneration Medicine and Stem Cell Research
Department of Neurology
University of California, San Francisco
San Francisco, California

Theodore G. Krontiris, MD, PhD
Director Emeritus, Comprehensive Cancer Center
Professor, Molecular Medicine
Full Member, Cancer Control and Population Sciences Program, Comprehensive Cancer Center
City of Hope
Duarte, California

Joseph C. Laning, PhD
Research Associate Professor of Molecular Medicine
Senior Director, UMass Human Stem Cell Bank & Registry
Shrewsbury, Massachusetts

Jane S. Lebkowski, PhD
Senior Vice President, Chief Scientific Officer
Geron Corporation
Menlo Park, California

Geoffrey Lomax, PhD
Senior Officer to the Standards Working Group
California Institute for Regenerative Medicine
San Francisco, California

Melissa J. Lopes, Esq,
Associate Director for Research Policy and Implementation
Harvard University
Office of the Vice Provost for Research
Cambridge, Massachusetts

Jeanne F. Loring, PhD
Professor of Developmental Neurobiology
Director of the Center for Regenerative Medicine
Department of Chemical Physiology
California Campus
The Scripps Research Institute
La Jolla, California

Wange Lu, PhD
Assistant Professor
Department of Biochemistry and Molecular Biology
Broad Center for Regenerative Medicine and Stem Cell Research
Keck School of Medicine of USC
Los Angeles, California

S. Peter Ludwig
Principal
Fish & Richardson
New York, New York

Drew Lyall
Executive Director
Stem Cell network (Canada)
Ottawa, Canada

Chris Mason, MBBS, PhD, FRCS
Professor
Regenerative Medicine Bioprocessing
Advanced Centre for Biochemical Engineering
University College London
London, United Kingdom

Michael H. May, PhD
Chief Executive Officer
Centre for Commercialization of Regenerative Medicine Toronto, Ontario

Martin McGlynn
Chief Executive Officer
StemCells, Inc.
Palo Alto, California

Ian K. McNiece, PhD
Professor,
Director Experimental and Clinical Therapies
Stem Cell Institute
University of Miami
Miami, Florida

Stephen Minger, PhD.
Global Director R&D, Cell Technologies
GE Healthcare
London, United Kingdom

Santiago Miriuka, MD MSc
Program Director, Heart Failure and Heart Transplantation,
Disc. of Cardiology, FLENI
Researcher, Laboratory of Cell Developmental Biology,
FLENI
Researcher, CONICET
Buenos Aires, Argentina

Christopher T. Moulding
Sr. Manager, Technology Advancement & Licensing
USC Stevens Institute for Innovation
Los Angeles, California

Keith Murphy
Chief Executive Officer
Organovo, Inc.
San Diego, California

Norio Nakatsuji, D.Sc.
Director
Institute for Integrated Cell-Material Science (iCeMS)
Kyoto University
Kyoto, Japan

Frank Pajonk, MD, PhD
Associate Professor, Department of Radiation Oncology
Faculty Member, UCLA Biomedical Physics Interdepartmental Graduate Program
Faculty Member, UCLA Molecular Toxicology Graduate Program
Member, JCCC Signal Transduction and Therapeutics Program Area
UCLA Jonnson Comprehensive Cancer Center
Los Angeles, California

Paul Patterson, PhD
Anne P. and Benjamin F. Biaggini Professor of Biological Sciences
California Institute of Technology
Pasadena, California

Steven Peckman
Associate Director
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
University of California, Los Angeles
Los Angeles, California

Martin Pera, PhD
Director
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
University of Southern California
Los Angeles, California

Laura Perin, PhD
Assistant Professor, Urology
Children’s Hospital Los Angeles
Los Angeles, California

Philip A. Pizzo, MD
Dean
Stanford University School of Medicine
Carl and Elizabeth Naumann Professor
Professor of Pediatrics and of Microbiology and Immunology
Palo Alto, California

Anne L. Plant, Ph.D.
Leader, Cell Systems Science Group
Biochemical Science Division
National Institute of Standards and Technology
Gaithersburg, Maryland

Dr. Brent Polk, MD
Vice President, Research
Director, The Saban Research Institute
Vice President, Pediatrics & Academic Affairs
Chairman, Department of Pediatrics, Keck School of Medicine of USC
Los Angeles, California

Kevin Price
Chief Executive Officer
Scottish Stem Cell Network
Roslin Biocentre
Roslin, Scotland

Carmen A. Puliafito, MD, MBA
Dean, Keck School of Medicine of USC,
May S. and John Hooval Dean's Chair in Medicine
Los Angeles, California

Raj K. Puri, MD, PhD
Director, Division of Cellular and Gene Therapies,
FDA, Center for Biologics Evaluation and Research
Bethesda, Maryland

Gary Rabin
Chief Executive Officer
Advanced Cell Technology, Inc.
Santa Monica, California

Prof. S. Ramaswamy
Dean, Institute for Stem Cell Biology and Regenerative Medicine (inSTEM)
National Center for Biological Sciences
India

Don Reed
Vice President for Public Policy
Americans for Cures Foundation
Palo Alto, California

Roman Reed
President
Roman Reed Foundation
San Francisco, CA

Brock C. Reeve
Executive Director
Harvard Stem Cell Institute
Cambridge, Massachusetts

Camillo Ricordi, MD
Stacey Joy Goodman Professor of Surgery
Distinguished Professor of Medicine, Biomedical Engineering, Microbiology and Immunology
Director, Cell Transplant Center and Diabetes Research Institute, University of Miami
Miami, Florida

Heather Rooke, PhD
Science Director
International Society for Stem Cell Research
Deerfield, Illinois

Beth E. Roxland, JD, M.Bioethics
Executive Director, New York State Task Force on Life and the Law
Special Advisor to the Commissioner on Stem Cell Research Ethics
New York, New York

Bobby W. Sandage, Jr., Ph.D.
President & CEO
Coronado Biosciences, Inc.
New York, New York

Sam Schmidt
Chairman
Sam Schmidt Paralysis Foundation
Las Vegas, Nevada

Mary Schneider
Legislative Advocate,
Children's Neurobiological Solutions (CNS) Foundation
San Diego, California

Jeff Sheehy
Governing Board Member
Independent Citizens Oversight Committee at the California Institute of Regenerative Medicine
San Francisco, California

Bernard Siegel, JD
Executive Director
Genetics Policy Institute
Wellington, Florida

Charles F. Simmons Jr. MD
Chair, Pediatrics
Director, Neonatology
Cedars Sinai Health Systems
Los Angeles, California

Douglas A. Sipp
Manager, Office for Science Communications and International Affairs
RIKEN Center for Developmental Biology
Kobe, Japan

Jonathan M.W.Slack, Ph.D., F.Med.Sci.
Director, Stem Cell Institute,
University of Minnesota
Minneapolis, Minnesota

Devyn M. Smith, PhD
Senior Director
Strategic Planning Group
Pfizer Worldwide R&D
Groton, Connecticut

Evan Y. Snyder, MD, PhD
Program Director, Professor
Stem Cells and Regenerative Biology
Sanford-Burnham Medical Research Institute
La Jolla, California

Mari Cleide Sogayar
Professor
Chemistry Institute, Biochemistry Dept.
NUCEL-Cell and Molecular Therapy Center
University of São Paulo
São Paulo, Brasil/Brazil

Lorraine and Chris Stiehl
Patient Advocate Coordinators
California Institute for Regenerative Medicine
San Francisco, CA

Margaret Sutherland, PhD
Program Director
NIH/NINDS
Bethesda, Maryland

Clive Svendsen, PhD
Director
Cedars-Sinai Regenerative Medicine Institute
Los Angeles, California

Mark J. Tager, MD
Medical Consultant
Stemedica Cell Technologies, Inc.
San Diego, California

Robert Tressler, Phd
Vice President of Research & Development
Cellerant Therapeutics
San Carlos, California

Avi Treves, PhD
Deputy Director
Cancer Research Center
Sheba Medical Center
Tel Hashomer, Israel

Alan Trounson, PhD
President
California Institute of Regenerative Medicine
San Francisco, California

Ann Tsukamoto, PhD
Executive Vice President, Research & Development
StemCells, Inc.
Palo Alto, California

Gil Van Bokkelen, PhD
Chairman and CEO
Athersys, Inc.
Cleveland, Ohio

Alain Vertes, PhD
Sloan Fellow
London Business School
London, United Kingdom

Norman Viner, MD
Chief, Clinical Trial Division
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetics Therapies Directorate
Health Products and Foods Branch
Health Canada
Ottawa, ON

Hadar Vismunski-Weinberg
General Counsel Global Branded Products & Innovative Ventures
Corporate Legal Department
Teva Pharmaceutical Industries
Petach Tikva, Israel

David Warburton OBE, DSc, MD, MMM, FRCP, FRCS, FRCPCH
Director, Developmental Biology and Regenerative Medicine Program
Saban Research Institute
Children’s Hospital Los Angeles
Los Angeles, California

Michael Werner
Partner
Holland & Knight
Washington, DC

Michael D. West, PhD
CEO
BioTime, Inc.
Emeryville, California

Jennifer Willert, MD
Associate Clinical Professor, Pediatrics / Rady Children's Hospital San Diego
Hematologic Malignancies Program
San Diego, California

Professor Sir Ian Wilmut, FRS, FRSE
Director
MRC Centre for Regenerative Medicine
Edinburgh, Scotland

Kevin M. Wilson
Director of Public Policy
The American Society for Cell Biology

Samuel Woodley, JD, PhD
Principal
Fish & Richardson
New York, New York

Mary Woolley
President
Research America
Alexandria, Virginia

Yang Xu, PhD
Professor, Section of Molecular Biology
University of California, San Diego
San Diego, California

Yoon-Sun Yang, MD, PhD
CEO
MEDIPOST, Co., Ltd.
Seoul, Korea

James J. Yoo, MD, PhD
Chief Scientific Officer and Associate Director
Professor
Wake Forest Institute for Regenerative Medicine
Wake Forest University Health Sciences
Winston-Salem, North Carolina

Wise Young, MD, PhD
Professor and Chair
W.M. Keck Center for Collaborative Neuroscience
Rutgers, The State University of New Jersey
New Brunswick, New Jersey

Nicholas A. Zacharides, PhD
Partner
Duane Ross, LLP                 
West Palm Beach, Florida

Xianmin Zeng, PhD
Associate Professor
Buck Institute for Aging Research
Novato, California

Kun Zhang, PhD
Assistant Professor
Department of Bioengineering
University of California at San Diego
La Jolla, California

Claudia Zylberberg, PhD
President & CEO
Akron Biotech
Boca Raton, Florida